Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Hofstra Northwell Academic Works (Hofstra Northwell School of Medicine)Not a member yet
9590 research outputs found
Sort by
Diving Deep Under the SuRRFace: Achieving MoreThan Just Compliance with ACGME ScholarlyActivity Mandate
The use of the NEJM Knowledge Plus online platform to supplement traditional pulmonology lectures: A resident-led educational quality improvement project
Educating ED Staff on Palliative Medicine and the Benefits of Initiating Consults at the ED: A Quality Improvement Project
Covid-Lateral Damage: The Impact of the Post-Covid Era on Emergency Medicine Residency Training
It works there too! Use of the endovascular occlusion balloon to rescue left subclavian vein injury during lead extraction
Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic.
The ongoing outbreak of severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2, or coronavirus disease 2019 (COVID-19)] was declared a pandemic by the World Health Organization on March 11, 2020. Worldwide, more than 65 million people have been infected with this SARS-CoV-2 virus, and over 1.5 million people have died due to the viral illness. Although a tremendous amount of medical progress has been made since its inception, there continues to be ongoing research regarding the pathophysiology, treatments, and vaccines. While a vast majority of those infected develop only mild to moderate symptoms, about 5% of people have severe forms of infection resulting in respiratory failure, myocarditis, septic shock, or multi-organ failure. Despite maximal cardiopulmonary support and invasive mechanical ventilation, mortality remains high. Extracorporeal membrane oxygenation (ECMO) remains a valid treatment option when maximal conventional strategies fail. Utilization of ECMO in the pandemic is challenging from both resource allocation and ethical standpoints. This article reviews the rationale behind its use, current status of utilization, and future considerations for ECMO in critically ill COVID-19 patients